We have compared anaesthetic maintenance and emergence characteristics of propofol and sevoflurane with the laryngeal mask airway (LMA) at commonly used doses in 185 ASA I-II patients, in a randomized, prospective study. Anaesthesia was induced with propofol 2.5-3.5 mg kg
Propofol is becoming increasingly popular for maintenance of anaesthesia, particularly for ambulatory surgery, 1 and sevoflurane is an acceptable alternative. [2] [3] [4] Both agents allow rapid changes in anaesthetic depth, a favourable emergence profile and minimal postoperative morbidity. Studies have compared propofol with sevoflurane anaesthesia in paralysed patients with the trachea intubated, and shown them to be similar in terms of cardiorespiratory effects, emergence times and adverse events. [2] [3] [4] The laryngeal mask airway (LMA) has gained widespread acceptance as a general purpose airway, with usage rates of up to 30%. 5 Large scale studies (total 18 410 patients) suggest it is safe and effective for spontaneous ventilation (8139 patients) and positive pressure ventilation (10 271 patients). [5] [6] [7] The LMA offers several advantages over the tracheal tube, including improved haemodynamic stability, reduced anaesthetic requirements for airway tolerance, lower frequency of coughing, improved oxygen saturation during emergence and less sore throat, 8 and does not require neuromuscular block. Although both propofol 9 and sevoflurane 10 have been used for maintenance of anaesthesia with the LMA, there have been no comparative studies evaluating their clinical efficacy.
In this randomized study, we have compared maintenance and emergence characteristics of sevoflurane-nitrous oxide with propofol-nitrous oxide anaesthesia at commonly used doses in non-paralysed patients undergoing ventilation with the LMA.
Patients and methods

This study was approved by the Research and Ethics
Committees of the University Hospital of Innsbruck and written informed consent was obtained from all patients. We studied 185 consecutive patients undergoing musculoskeletal surgery expected to last more than 30 min in the supine position, allocated randomly to one of four treatment groups. In groups I and II anaesthesia was maintained with 66% nitrous oxide in oxygen and infusion of propofol 6 or 8 mg kg 91 h
91
, respectively. In groups III and IV anaesthesia was maintained with 66% nitrous oxide in oxygen and either 1% or 1.5% end-tidal sevoflurane, respectively. Sample size was based on the need to show a 20% difference in orientation time between groups, with a type I error of 0.05 and a power of 0.8.
Patients were excluded if they were less than 19 or more than 65 yr of age, ASA III-V, had a history of malignant hyperthermia, respiratory tract pathology, a sore throat within 10 days, known difficult airway, body mass index greater than 30 kg m 92 or were at risk of regurgitation/aspiration (previous upper gastrointestinal tract surgery, known or symptomatic hiatus hernia, oesophageal reflux, peptic ulceration or not fasted).
Patients were allocated randomly to treatment groups by opening sealed envelopes, 1-2 h before operation. Anaesthesia was standardized. Premedication comprised midazolam 7.5 mg orally approximately 1 h before induction. Monitoring was started before induction of anaesthesia and included ECG, pulse oximetry, capnography and non-invasive arterial pressure. Oxygen was given by face mask and then fentanyl 1-3 g kg 91 was given followed 1 min later by propofol 2.5-3.5 mg kg 91 over 30 s. Immediately before insertion, the LMA was lubricated with saline. No attempt was made to ventilate the patient's lungs via a face mask or to instrument the airway with suction catheters at any time during anaesthesia. The LMA was inserted 30 s after completion of the bolus dose of propofol using the standard recommended insertion technique, 11 with the cuff deflated and the rim facing posteriorly when the eyelash reflex was lost and the jaw relaxed. A size 3 LMA was used for patients weighing 30-60 kg and a size 4 for patients more than 60 kg (size 5 LMA was unavailable during the study). Additional bolus doses of propofol 0.5 mg kg 91 were given as required until an adequate level of anaesthesia was achieved for placement. All LMA were inserted by a single experienced user (C. K.) (more than 800 previous placements). The cuff was initially inflated with 20 ml of air in the size 3 and 30 ml in the size 4. Successful placement was judged by chest wall movement and capnography during manually assisted ventilation. After successful placement, the LMA was fixed in place in the midline with the tube following its natural caudal curve using adhesive tape. 11 A wad of gauze swabs rolled into a cylindrical shape was placed alongside the LMA to function as a bite block. 11 Cuff pressures were monitored throughout the procedure using a calibrated aneroid manometer (Mallinckrodt Medical, Athlone, Ireland) which was attached to the pilot balloon. Cuff pressures were maintained at less than 60 cm H 2 O by intermittently withdrawing gas from the cuff. Patients underwent positive pressure ventilation (PPV) with tidal volumes of 6-8 ml kg 91 and peak airway pressures were limited to 15 cm H 2 O. Ventilatory frequency was adjusted to maintain end-tidal carbon dioxide in the normal range (4.4-5.3 kPa).
Anaesthesia was maintained with 66% nitrous oxide in oxygen and propofol 6 or 8 mg kg 91 h 91 , or 1.0% or 1.5% end-tidal sevoflurane. Airway gases were sampled from the proximal end of the LMA. A circle anaesthetic breathing system was used and there was no active humidification in the anaesthesia system. Fresh gas flows were 2 litre min 91 of oxygen and 4 litre min 91 of nitrous oxide. Depth of anaesthesia was assessed by observing ventilatory frequency, patient movement, heart rate and arterial pressure and, if considered inadequate, fentanyl 1 g kg 91 was given. If coughing, retching or laryngospasm occurred, propofol 0.5 mg kg 91 was given. The maintenance dose of propofol or sevoflurane was continued until completion of surgery. Emergence took place in the operating room in the supine position with the patient undisturbed and breathing 100% oxygen. LMA removal time was determined by asking the patient in a normal tone of voice to open his or her eyes and mouth. This was repeated every 15-30 s until both appropriate responses were obtained. The LMA and bite block were removed simultaneously and the time recorded. Orientation time was determined by asking the patient in a normal tone of voice to state his or her name and date of birth. This was repeated every 15-30 s until a correct response was obtained and the time recorded.
Patient data, including sex, age, weight, smoking history and duration of surgery were recorded for each patient. In addition to the standard anaesthetic record, mean arterial pressure (MAP) and heart rate (HR) were recorded before induction, every minute from induction to incision, every 5 min after incision, and every minute after anaesthesia was discontinued until the LMA was removed. Problems during induction and surgery were documented by the anaesthetist (C. K.) not blinded to the type of anaesthetic. F 933%), coughing, retching, hiccup, laryngospasm (a sudden increase in peak airway pressure greater than 25 cm H 2 O), bronchospasm, regurgitation, aspiration, gastric insufflation (air heard entering the stomach on auscultation over the epigastrium), increased salivation, biting and any other untoward airway event.
Haemodynamic problems included hypertension/ hypotension, tachycardia/bradycardia and other arrhythmias. Hypertension or hypotension was defined as MAP<20% of preinduction baseline values, respectively. Tachycardia or bradycardia was defined as heart rate greater that 100 beat min 91 or less than 60 beat min
, respectively. Excitatory phenomena included inco-ordinate movement, shivering and straining. Successful induction, maintenance and emergence were defined as the absence of any respiratory or cardiovascular problems during that time. Anaesthesia was divided into three phases: induction (start of anaesthesia until successful placement of the LMA); maintenance (successful placement of the LMA until anaesthesia discontinued) and emergence (anaesthesia discontinued until patient orientated). Time intervals recorded included anaesthesia time (start of anaesthesia until anaesthesia discontinued), LMA removal time (anaesthesia discontinued until LMA removed) and orientation time (anaesthesia discontinued until patient orientated).
Each patient underwent a structured interview (H. S.) 18-24 h after surgery during which they were asked about postoperative hoarseness (yes/no), nausea (yes/no) and vomiting (yes/no). Sore throat was graded by the patient as none (no sore throat at any time since the operation), mild (sore throat disappeared within 6 h), moderate (sore throat disappeared within 12 h) and severe (sore throat lasted 12 h or more).
Data were analysed with the Student's t test and chi-square test using the software package SPSS (version 6.0 for Windows, SPSS Inc., Chicago, IL, USA). Significance was taken as P:0.05.
Results
There were no significant differences between the four groups in age, weight, height, body mass index, ASA status, sex distribution, smoking history, type of surgical procedure, anaesthesia time, administration of adjunctive drugs and induction doses of fentanyl and propofol (table 1) .
Problems occurring during the three phases of anaesthesia are given in table 2. There were no failed insertion attempts and adequate ventilation was achieved in all patients. The lowest oxygen saturation recorded during the study was 95%. There were no episodes of gastric distension, regurgitation, aspiration or bronchospasm. The incidence of problems at induction was similar in all groups. During maintenance, the incidence of laryngospasm and requirements for additional propofol were greater with 1% sevoflurane (95% confidence intervals (CI) 2-23%) compared with 1.5% sevoflurane (95% CI 0-8%) or the propofol groups (95% CI 0-7%). During emergence, there was a greater incidence of excitatory phenomena with 1% and 1.5% sevoflurane (95% CI 4-9%) compared with propofol (95% CI 0-4%).
HR ( fig. 1 ) and MAP ( fig. 2) for each group were similar during induction and maintenance of anaesthesia. There was no haemodynamic stress response to placement of the LMA. During emergence, HR was greater with sevoflurane at 3-7 min after discontinuation of anaesthesia (P:0.05). MAP was similar. 
The total number of patients with respiratory and haemodynamic problems during each phase of anaesthesia is given in table 3. Sevoflurane 1.0% (95% CI 37-71%) was associated with the greatest overall incidence of respiratory and haemodynamic problems. This was significantly higher compared with propofol 6 mg kg 91 h 91 (95% CI 19-36%), but there were no other significant differences between groups. Significantly shorter times to LMA removal and orientation were observed with 1% and 1.5% sevoflurane compared with propofol 6 and 8 mg kg 91 h 91 (P:0.0002). Removal and orientation times were similar for 1% sevoflurane compared with 1.5% sevoflurane, and similar for propofol 6 and 8 mg kg 91 h
91
. Postoperative problems did not differ between groups. The incidence of sore throat was 2.7% and hoarseness 0%. The number of patients who received postoperative analgesia was similar between groups.
Discussion
Our data suggest that maintenance of anaesthesia with propofol 6-8 mg kg 91 h 91 or 1.5% sevoflurane in nitrous oxide provides satisfactory anaesthetic conditions in non-paralysed patients undergoing ventilation with an LMA. Sevoflurane 1.0% provided less satisfactory conditions and this was probably related to inadequate depth of anaesthesia. The overall incidence of problem-free maintenance and emergence was similar to that reported in paralysed patients whose tracheas were intubated, 3 but randomized controlled studies are required to determine if either technique offers an advantage.
During induction and maintenance of anaesthesia, haemodynamic variables were similar. This contrasts with the results of Fredman and colleagues who showed slower heart rates in the immediate postinduction period in paralysed patients whose tracheas were intubated. 2 The reason for this difference is not clear. During emergence, heart rate was greater with sevoflurane. MAP was similar in all groups during emergence. The high incidence of bradycardia in all groups may reflect the lack of cardiovascular stimulation resulting from the LMA.
The efficacy of the LMA technique for PPV is already established, but most controlled studies involve paralysed patients. 7 12-15 Our data suggest that the technique is also suitable for non-paralysed patients. It is interesting that, despite cuff pressure limitation to 60 cm H 2 O, in all patients ventilation was adequate using tidal volumes of 6-8 ml kg 91 and peak airway pressures of 15 cm H 2 O. This may be related to the relatively low body mass index of the study population (BMI :30 kg m
92
) and accurate placement of the device. Dyer, Llewellyn and James have shown the LMA to be an effective device for PPV using total i.v. anaesthesia with propofol and easier to manage than the tracheal tube in the absence of neuromuscular blockers. 9 The times required for LMA removal and orientation were shorter with sevoflurane. These times Figure 1 Heart rate (HR) before induction of anaesthesia, at the indicated times after induction, at skin incision, at the indicated times after skin incision, at the end of administration of anaesthesia and at the indicated times after anaesthesia in the four treatment groups (mean (SD)). HR was significantly greater with sevoflurane at 3-7 min after discontinuation of anaesthesia. Figure 2 Mean arterial pressure (MAP) before induction of anaesthesia, at the indicated times after induction, at skin incision, at the indicated times after skin incision, at the end of administration of anaesthesia and at the indicated times after anaesthesia in the four treatment groups (mean (SD)). There were no significant differences between groups. were similar to those reported for sevoflurane and propofol in paralysed patients whose tracheas were intubated. 2 3 The highest incidence of nausea (7%) and vomiting (2%) was in the 1.5% sevoflurane group, but this was not significantly different from the other groups. The incidence of nausea and vomiting was 2-10 times less than previously reported for paralysed patients whose tracheas were intubated 3 and may reflect different methods of data collection, different types of surgery or antiemetic therapy. It would seem unlikely that this was related to the LMA as previous studies have reported a similar incidence of postoperative nausea and vomiting when comparing the LMA with the tracheal tube. 16 17 No routine intraoperative antiemetic was given in our study and there was no case of gastric insufflation.
The incidence of sore throat with the LMA is approximately 10%, but varies between 0 and 50%, [18] [19] [20] [21] [22] [23] and the incidence of hoarseness is approximately 4%. [21] [22] [23] [24] The incidence of sore throat and hoarseness in our study was low (2.7% and 0%, respectively). This probably reflects the high first time placement rate, use of standard insertion technique and adoption of low intra-cuff pressures. All LMA were inserted by an experienced user with more than 800 previous placements. It has been shown that there are short-term (975 uses) 25 and long-term (9750 uses) 6 learning curves with the LMA. Burgard, Mollhoff and Prien demonstrated that reducing cuff pressure to the minimum required for an adequate seal produced a reduction in sore throat from 8 to 0%. 22 The 13% incidence of biting during emergence highlights the importance of using a bite block with the LMA.
We conclude that propofol 6-8 mg kg 91 h 91 and 1.5% end-tidal sevoflurane were suitable for maintenance of anaesthesia for musculoskeletal surgery in non-paralysed ASA I-II patients undergoing PPV with the LMA. Emergence was more rapid with sevoflurane, but was associated with more excitatory phenomena and tachycardia.
